Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities

Kurt Ullman  |  Issue: December 2017  |  December 18, 2017

Dr. Barbhaiya

Dr. Barbhaiya

A recent epidemiologic study of patients with systemic lupus erythematosus (SLE) investigated racial and ethnic differences in the risk for cardiovascular disease (CVD). Among SLE patients enrolled in Medicaid, the risk for myocardial infarction (MI) was lower in Hispanics and Asians compared with whites, and the risk of stroke was higher in blacks and Hispanics compared with whites.1

“The risk of CVD is known to be greatly elevated among SLE patients and is the major cause of death in SLE,” says Medha Barbhaiya, MD, MPH, an assistant attending physician at the Hospital for Special Surgery and an assistant professor at Weill Cornell Medical College in New York City. “It is also known that Hispanic, Asian and African Americans in the United States have higher incidence of SLE than whites, and often more severe disease. However, the role of patient race and ethnicity in relation to risk of CVD previously has not been well understood.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Study

The researchers used the Medicaid Analytic eXtract to identify patients between 18 and 65 years old with an SLE diagnosis and at least 12 months of continuous enrollment. The study ran from 2000–2010. The researchers followed the subjects from their SLE index date to their first CVD event, MI or stroke (if any), or death, dis­enrollment, loss to follow-up or end of the follow-up period. Of the 65,788 SLE patients enrolled, 93% were women, roughly 42% were black, 48% were white, 16% were Hispanic, 3% were Asian, and 1% were Native American/Alaskan Native. The mean follow-up time was 3.8 years.

CVD rates were highest among blacks, with an incidence rate (IR) of 10.57, and lowest among Asians, with an IR of 6.63. After multivariable adjustment, the risk of CVD events was elevated among blacks, with a hazard ratio (HR) of 1.14, compared with whites. When examining MI or stroke risk separately, Hispanics and Asians had a lower risk, with an HR of 0.61 and 0.57, respectively, compared with white SLE patients enrolled in Medicaid. Blacks and Hispanics had a higher risk for stroke than whites, with an HR of 1.31 and 1.22, respectively. Among all patients, the annual CVD event IR per 1,000 person-years measured 9.31. All rates came with a 95% CI.

A recent epidemiologic study of patients with SLE investigated racial and ethnic differences in the risk for cardiovascular disease.

A recent epidemiologic study of patients with SLE investigated racial and ethnic differences in the risk for cardiovascular disease.
Rawpixel.com / SHUTTERSTOCK.COM

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:ACR JournalAmerican College of Rheumatology (ACR)Cardiovascular diseasecomorbiditiesethnicitiesheartHispanicLupusMyocardial infarctionoutcomepatient careraceResearchrheumatologistrheumatologyriskstrokestudySystemic lupus erythematosus

Related Articles

    Racial Bias Found in Pain Assessment, Management, Treatment Recommendations by Clinicians

    October 10, 2016

    In the world of evidence-based medicine, basing diagnosis and treatment decisions on belief instead of data seems anachronistic. And yet … clinicians are human, and humans live in culture, and culture is formed by beliefs, and beliefs (consciously or unconsciously) drive perception and, often, action. So a new study shining a light on racial bias…

    Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

    September 8, 2016

    Be careful when prescribing allo­purinol to black and Asian gout patients, a study newly advises. Black and Asian patients who take this ubiquitous, more-than-40-year-old medication are at much higher risk of certain serious skin reactions than are Caucasians or Hispanics. Compared with Caucasians, blacks who take allopurinol to lower blood urate levels have an increased…

    Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus

    April 20, 2017

    WASHINGTON, D.C.—Experts at the 2016 ACR/ARHP Annual Meeting session, Systemic Lupus Erythematosus—Clinical Aspects and Treatment IV: Biomarkers, reported on a number of recent studies showing advancement in our understanding of the disease mechanisms underlying systemic lupus erythematosus (SLE) that place these patients at risk for cardiovascular disease (CVD) and other comorbidities. Mechanisms of CVD Risk…

    Study Finds NSAIDs Raise Heart Disease Risk in Osteoarthritis Patients

    February 16, 2021

    In a controlled, large-cohort, longi­tudinal study from Canada, Atiquazzaman et al. found that use of non-steroidal anti-inflammatory drugs (NSAIDs) substantially contributes to increased cardiovascular disease risk among people with osteoarthritis (OA).1  This is the first study to evaluate the mediating role that NSAIDs play in the association between OA and cardiovascular disease (CVD), and the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences